| 1 |
33631989 | Plasticity of Treg and imbalance of Treg/Th17 cells in patients with systemic sclerosis modified by FK506. | 2021 Jan-Dec |
1 |
| 2 |
31838663 | Tacrolimus Inhibits TNF-α/IL-17A-Produced pro-Inflammatory Effect on Human Keratinocytes by Regulating IκBζ. | 2020 Apr |
5 |
| 3 |
32817992 | Tacrolimus Improves the Implantation Rate in Patients with Elevated Th1/2 Helper Cell Ratio and Repeated Implantation Failure (RIF). | 2020 Aug |
1 |
| 4 |
30472069 | Tacrolimus inhibits Th1 and Th17 responses in MuSK-antibody positive myasthenia gravis patients. | 2019 Feb |
2 |
| 5 |
31024070 | Low-Dose Tacrolimus Prevents Dysregulated Peri-Conceptional Ovarian and Systemic Immune Cellular Homeostasis in Subjects with PCOS. | 2019 Apr 25 |
1 |
| 6 |
25905982 | Differential Effects of Calcineurin and Mammalian Target of Rapamycin Inhibitors on Alloreactive Th1, Th17, and Regulatory T Cells. | 2015 Sep |
1 |
| 7 |
23626544 | Successful treatment of plasmacytosis circumorificialis with topical tacrolimus: two case reports and an immunohistochemical study. | 2013 Jan |
1 |
| 8 |
22579702 | Tacrolimus potently inhibits human osteoclastogenesis induced by IL-17 from human monocytes alone and suppresses human Th17 differentiation. | 2012 Aug |
8 |
| 9 |
21818055 | Impact of mycophenolic acid and tacrolimus on Th17-related immune response. | 2011 Aug 27 |
1 |
| 10 |
20159692 | [Effect of FK506 on cytokine secretion in whole blood]. | 2010 Feb |
2 |
| 11 |
18957484 | Inhibition of tumour necrosis factor and IL-17 production by leflunomide involves the JAK/STAT pathway. | 2009 Oct |
1 |
| 12 |
18262659 | Clinical efficacy and cytokine network-modulating effects of tacrolimus in myasthenia gravis. | 2008 Mar |
1 |
| 13 |
17161467 | Cyclosporine A inhibits IL-15-induced IL-17 production in CD4+ T cells via down-regulation of PI3K/Akt and NF-kappaB. | 2007 Jan 15 |
1 |